Skip to main content
. Author manuscript; available in PMC: 2014 Sep 18.
Published in final edited form as: Eur J Med Chem. 2011 Nov 15;47(1):432–444. doi: 10.1016/j.ejmech.2011.11.012

Table 2. Summary of altered cell cycle distribution in response to treatment with CSUOH0901(NSC751382).

SKBR-3 cells were treated for different time period with the indicated concentrations of compound. Cells were processed for FACS using propidium iodide staining as described. Percent distribution of cells in each cell cycle phase was displayed.

Time Concentrations
of CSUOH0901
Sub-G1 % G1 % S % G2/M %
3h 0.10(μM) 3.12 70.84 17.20 8.83
0.25(μM) 3.23 69.63 16.34 10.77
0.50(μM) 3.43 67.14 17.76 11.54
5.0(μM) 2.81 69.09 16.49 11.57

6h 0.10(μM) 3.60 71.43 15.84 9.07
0.25(μM) 3.49 72.21 14.95 9.32
0.50(μ M) 4.03 67.10 14.73 13.90
5.0(μM) 3.42 64.76 14.61 17.19

12h 0.10(μM) 5.27 73.14 8.17 12.05
0.25(μM) 6.85 73.62 6.14 13.35
0.50(μM) 6.36 63.15 5.94 24.26
5.0(μM) 9.76 63.71 5.99 20.54

18h 0.10(μM) 6.04 75.43 8.71 9.71
0.25(μM) 8.89 73.42 6.81 10.57
0.50(μM) 8.47 61.19 7.28 22.27
5.0(μM) 8.31 63.55 6.73 21.80

24h 0.10(μM) 11.78 67.90 8.91 11.23
0.25(μM) 24.95 41.27 10.87 22.53
0.50(μM) 27.94 31.77 11.21 28.14
5.0(μM) 27.62 31.87 11.53 28.29